William Kridel is a Founding Partner at HOF. He is also the Founder of Ferghana Partners, an investment bank specializing in life sciences.. He was previously a Managing Director with responsibility for corporate finance and M&A advisory services for certain business sectors at BZW, the merchant banking arm of Barclays Bank in London.

Following the sale of his investment banking company, The Kridel Group, to Peers & Company in 1988, Bill ran its European operations from the Paris office of this investment banking affiliate of the Long Term Credit Bank of Japan until early 1991 when he joined Barclays. The Kridel Group specialized in mergers and acquisitions, divestitures, and equity private placements. From 1971-1977, Bill was a Vice President in the International Corporate Finance Department at Baring Bros. & Co. in London and Paris. From 1970-1971, Bill worked in the International Finance and Acquisition group at Banque Paribas in Paris.

Honors graduations from Choate School, Yale University (BA), and Columbia Law School (JD), and attendance at other institutions for business and chemical engineering. Bill qualified as an attorney in the United States, successfully gaining the license to practice before many bars, including New York State, Patent Court, and the US Supreme Court, and also practiced law (M&A/financings) at Shearman & Sterling.

• Investment Banking Founder/Managing Director, Ferghana Partners (33yrs)
• J.D., Columbia Law School
• B.A., Yale University
• Executive Chairman, One30Seven (nuclear waste reduction); Triage Technologies (AI-powered, Internet-based dermatological analysis); Emergex USA (subsidiary of UK parent, T-cell immunotherapy for infectious diseases and cancer); and formerly at HealthShares (19 thematic ETFs, listed on NYSE)
• Board Member, Trenchant Biosystems Inc. (automated, desktop production equipment of cells)